Invention Grant
- Patent Title: Pharmaceutical compositions
-
Application No.: US16784498Application Date: 2020-02-07
-
Publication No.: US10772877B2Publication Date: 2020-09-15
- Inventor: Magnus Brisander , Mustafa Demirbüker , Gérald Jesson , Martin Malmsten , Helene Dérand
- Applicant: XSPRAY MICROPARTICLES AB
- Applicant Address: SE Solina
- Assignee: XSPRAY MICROPARTICLES AB
- Current Assignee: XSPRAY MICROPARTICLES AB
- Current Assignee Address: SE Solina
- Agency: Merchant & Gould P.C.
- Agent Daniel R. Evans
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@1801695c com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@6073b23b
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/48 ; A61K38/00 ; A61K31/497 ; A61K31/505 ; B01F3/00 ; A61K31/44 ; A61K31/517 ; A61K9/00 ; A61K9/16 ; A61K31/444 ; A61K9/51 ; A61K47/38 ; A61K47/32 ; A61K31/5377 ; A61K31/4545 ; A61K31/4439 ; A61K31/506 ; A61K31/437
Abstract:
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.
Public/Granted literature
- US20200253941A1 PHARMACEUTICAL COMPOSITIONS Public/Granted day:2020-08-13
Information query
